Tandem Diabetes Care Inc (NASDAQ: TNDM) kicked off on Monday, up 3.37% from the previous trading day, before settling in for the closing price of $21.39. Over the past 52 weeks, TNDM has traded in a range of $9.98-$38.28.
During the last 5-year period, the sales drop of Healthcare Sector giant was -28.23%. While this was happening, its average annual earnings per share was recorded -45.24%. With a float of $67.09 million, this company’s outstanding shares have now reached $67.77 million.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 1.05%, while institutional ownership is 112.45%. The most recent insider transaction that took place on Aug 11 ’25, was worth 102,318. In this transaction PRESIDENT & CEO of this company bought 10,000 shares at a rate of $10.23, taking the stock ownership to the 106,327 shares. Before that another transaction happened on Aug 08 ’25, when Company’s EVP & CHIEF FINANCIAL OFFICER bought 13,720 for $10.89, making the entire transaction worth $149,404. This insider now owns 25,580 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.44 earnings per share (EPS), lower than consensus estimate (set at -0.24) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -45.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.94% during the next five years compared to -28.23% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Take a look at Tandem Diabetes Care Inc’s (TNDM) current performance indicators. Last quarter, stock had a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.05, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.91 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 1.98 million, which is a jump from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 76.89%.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 99.59%, which indicates a significant increase from 98.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.13 in the past 14 days, which was higher than the 0.89 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.37, while its 200-day Moving Average is $17.06. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $22.41. Second resistance stands at $22.70. The third major resistance level sits at $23.25. If the price goes on to break the first support level at $21.57, it is likely to go to the next support level at $21.02. Now, if the price goes above the second support level, the third support stands at $20.73.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
The company with the Market Capitalisation of 1.50 billion has total of 67,802K Shares Outstanding. Its annual sales at the moment are 940,200 K in contrast with the sum of -96,030 K annual income. Company’s last quarter sales were recorded 249,250 K and last quarter income was -21,170 K.
